LoadingLoadingLoading34 funds hold it.Insiders net selling.
Net selling: insiders sold $118.2M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $3K to $45K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsLast report
Oct 29, 2026
Financial period
Q3 2026
Earnings per share
$3.55 expected
Revenue
$6.62B expected
Estimates as of Nov 4, 2026
EPS expected
$4.99 to $5.05
Revenue expected
22 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 29, 2026 | $3.52est. $3.55 | -0.77%in line | $6.52Best. $6.62B-1.47% | +7.6%from $6.06B |
| Jun 30, 2026Reported Jul 30, 2026 | $3.69est. $3.49 | +5.79%beat | $6.59BSEC filing | +9.4%from $6.02B |
| Mar 31, 2026Reported Apr 30, 2026 | $2.60est. $2.98 | -12.86%miss | $6.02BSEC filing | +2.6%from $5.87B |
| Dec 31, 2025Reported Jan 29, 2026 | $4.47est. $4.40 | +1.70%beat | $7.17BSEC filing | +11.4%from $6.44B |
| Sep 30, 2025Reported Oct 30, 2025 | $3.19est. $3.13 | +1.92%beat | $6.06BSEC filing | +10.2%from $5.49B |
| Jun 30, 2025Reported Jul 31, 2025 | $3.13est. $3.07 | +1.95%beat | $6.02BSEC filing | +11.1%from $5.42B |
| Mar 31, 2025Reported May 1, 2025 | $2.84est. $2.73 | +4.03%beat | $5.87BSEC filing | +11.9%from $5.24B |
| Dec 31, 2024Reported Jan 28, 2025 | $4.01est. $3.87 | +3.62%beat | $6.44BSEC filing | +10.7%from $5.82B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $7.17B | $6.02B | $6.59B | $6.52B |
| Cost of what it sold | $2.49B | $2.21B | $2.09B | $2.27B |
| Gross profit | $4.68B | $3.81B | $4.50B | $4.25B |
| What it spent | ||||
| Research and development | $401.0M | $413.0M | $434.0M | $433.0M |
| Sales and admin | $2.13B | $2.28B | $2.23B | $2.31B |
| Other operating costs | $180.0M | $180.0M | $176.0M | $468.0M |
| Total operating expenses | $2.72B | $2.87B | $2.84B | $3.21B |
| What was left | ||||
| Operating profit | $1.96B | $936.0M | $1.66B | $1.03B |
| Interest on debt | $381.0M | $148.0M | $141.0M | $143.0M |
| Profit before tax | $1.71B | $850.0M | $1.56B | $997.0M |
| Tax | $856.0M | $105.0M | $288.0M | $244.0M |
| Net profit | $849.0M | $745.0M | $1.28B | $753.0M |
| EBITDA | $2.03B | $1.30B | $2.00B | $1.29B |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bearish
Stryker Corp at Citigroup Inc Unplugged Medtech and Life Sciences Access Day Transcript
NeutralNov 3Is Intuitive Surgical Stock Worth More Than Its Competitors?
NeutralNov 3A Memo To Stryker’s Orthopaedics Team About Winning Again
Leans bearishNov 3Stryker invests US$400m in CMR Surgical and secures option to acquire business
BullishNov 3Mercury Systems (MRCY) Set to Announce Quarterly Earnings on Tuesday
NeutralNov 3Rep. Thomas H. Kean, Jr. Buys Shares of ESAB Corporation (NYSE:ESAB)
Leans bearishNov 3Stifel cuts Stryker stock price target on weak quarter, guidance By Investing.com
BearishNov 3Stryker Shares Post Their First 5% Daily Gain in 321 Sessions of Data
BullishNov 3
